As of 2026-01-21, the Intrinsic Value of Olema Pharmaceuticals Inc (OLMA) is -9.53 USD. This OLMA valuation is based on the model Peter Lynch Fair Value. With the current market price of 26.72 USD, the upside of Olema Pharmaceuticals Inc is -135.67%.
Based on its market price of 26.72 USD and our intrinsic valuation, Olema Pharmaceuticals Inc (OLMA) is overvalued by 135.67%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -9.53 - -9.53 | -9.53 | -135.67% |
| P/E | (39.96) - (45.14) | (45.61) | -270.7% |
| DDM - Stable | (11.76) - (34.92) | (23.34) | -187.4% |
| DDM - Multi | (9.08) - (21.59) | (12.85) | -148.1% |
| Market Cap (mil) | 2,101.80 |
| Beta | 0.05 |
| Outstanding shares (mil) | 78.66 |
| Enterprise Value (mil) | 2,069.54 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.13% |
| Cost of Debt | 5.00% |
| WACC | 7.90% |